Today: 20 May 2026
Browse Category

NASDAQ:LBTYB 21 June 2025 - 7 February 2026

Liberty Global stock price jolts as rarely traded LBTYB jumps; LBTYA ticks up into earnings

Liberty Global stock price jolts as rarely traded LBTYB jumps; LBTYA ticks up into earnings

Liberty Global’s Class B shares (LBTYB) surged 86% Friday, peaking at $51.24 before closing at $22.40 on heavy volume, with no new filings or news. Class A and C shares both rose 1.4% to $11.42. The company will report full-year results on February 18. Liberty Global and Telefonica are also preparing a £2 billion bid for UK broadband provider Netomnia, according to the Financial Times.
6 February 2026
····

Stock Market Today

  • Okta (OKTA) Stock Declines Amid Market Despite Strong Earnings Outlook
    May 19, 2026, 7:32 PM EDT. Okta (OKTA) shares fell 1.68% to $74.45, underperforming the S&P 500's slight 0.02% decline. The cloud identity management firm is expected to report earnings per share (EPS) of $0.57, a 29.55% increase year-over-year, and revenue of $649.35 million, up 11.19%. Annual forecasts predict EPS of $2.61 and revenue of $2.56 billion, marking increases of 63.13% and 13.19%, respectively. Despite the recent stock drop, Okta holds a Zacks Rank #1 (Strong Buy), reflecting optimistic analyst revisions. The stock trades at a forward price-to-earnings ratio of 29.07, above the industry average of 17.59, and a PEG ratio of 1.26 compared to the industry's 1.58, indicating valuation relative to earnings growth.

Latest articles

James Hardie Drops After Warning on Housing, Even With Q4 Beat

James Hardie Drops After Warning on Housing, Even With Q4 Beat

20 May 2026
James Hardie’s U.S.-listed shares dropped 6.1% Tuesday and slid another 2.6% after hours after reporting a 35% fall in quarterly net income to $28.5 million, despite a 45% jump in net sales to $1.40 billion. The company cited weak housing demand and warned the market remains uncertain. ASX shares had not traded post-earnings; they last closed at A$26.78, up 2.9%.
SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

20 May 2026
SELLAS Life Sciences shares rose 4.1% to $7.59 Tuesday after CEO Angelos Stergiou said its Phase 3 AML trial is two events from final analysis. The company reported $107.1 million in cash and a first-quarter net loss of $8.4 million. The REGAL trial’s main measure is overall survival. SELLAS remains blinded to results until the 80th event triggers data review.
Red Robin Shares Rise After Earnings Beat

Red Robin Shares Rise After Earnings Beat

20 May 2026
Red Robin shares surged 15.6% after hours to $4.45 Tuesday, following first-quarter revenue of $378.3 million that beat Wall Street estimates despite a 0.6% drop in comparable sales and a 1.6% decline in guest traffic. Net loss was $2.2 million, or 12 cents per share. The company reaffirmed its 2026 outlook and said refranchising talks are in final stages.
Go toTop